Respiratory News and Research

RSS

Study: Combining non-invasive ventilation and home oxygen therapy can reduce hospital readmissions for chronic COPD patients

Recently published advancements in pulmonary research suggest that the combination of non-invasive ventilation and home oxygen therapy can significantly prolong time to readmission or death for patients with chronic obstructive pulmonary disease following a life-threatening respiratory event or exacerbation.

26 May 2017

FIRS releases new report that outlines global burden of respiratory disease

The Forum of International Respiratory Societies, an organization comprised of the world’s leading international respiratory societies working together to improve lung health globally, today released “The Global Impact of Respiratory Disease.” The report lays out the tremendous impact that respiratory disease has on world health.

26 May 2017

ERT’s Centralized LCI Services improve data quality to measure disease progression in respiratory clinical trials

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today introduced an advanced respiratory clinical trial solution to centrally capture, measure and analyze Lung Clearance Index data, in near real-time, to assess lung performance with more precision than traditional spirometry measures.

26 May 2017

Philips sponsors research to help COPD patients breathe easier

Recently published advancements in pulmonary research suggest that the combination of non-invasive ventilation (NIV) and home oxygen therapy (HOT) can significantly prolong time to readmission or death for patients with chronic obstructive pulmonary disease (COPD) following a life-threatening respiratory event or exacerbation. The five-year, multi-center study resulted in prolonged median time to readmission or death by nearly three months, and improved patient health-related quality of life in the first six weeks.

From Philips Healthcare 26 May 2017

Bedfont Scientific named as one of top 25 companies on the Future List

Bedfont is a small family business that specialised in the design and manufacture of breath and gas analysis monitors for medical application for over 40 years.

From Bedfont® Scientific Ltd 25 May 2017

EarlySense introduces new version of integrated patient monitoring and data analytics software platform

EarlySense, the market leader in contact-free continuous monitoring solutions, announced today the latest version of its integrated patient monitoring and data analytics software platform.

25 May 2017

Zephyr Endobronchial Valves demonstrate clinical efficacy in heterogeneous and homogenous emphysema patients

Pulmonx, Inc. today announced the results of two multi-center, randomized clinical trials showing clinically meaningful improvements in lung function after treatment with the Zephyr Endobronchial Valve (EBV) in emphysema patients without collateral ventilation.

25 May 2017

BGU researchers redesign portion of FDA-approved drug into new molecule to treat ALS

Ben-Gurion University of the Negev researchers are developing a new therapy for Amyotrophic Lateral Sclerosis using part of an existing FDA-approved drug that restores the central nervous system's (CNS) immune defenses and increases life expectancy.

25 May 2017

BU professor receives Research Innovation and Translation Achievement Award from ATS

Avrum Spira, MD, MSc, professor of medicine, pathology and bioinformatics at Boston University School of Medicine, is the inaugural recipient of the Research Innovation and Translation Achievement Award from the American Thoracic Society.

24 May 2017

Innovus Pharma announces launch of AllerVarx for relieving nasal, ocular symptoms in allergic patients

Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and women's health and respiratory diseases, today announced the launch of AllerVarx in the U.S.

24 May 2017

Lung cancer diagnosis may put patients at greatest risk of suicide, study finds

A lung cancer diagnosis appears to put patients at the greatest risk of suicide when compared to the most common types of non-skin cancers, according to new research presented at the ATS 2017 International Conference.

23 May 2017

Francis Crick Institute signs new research agreement with AstraZeneca

The Francis Crick Institute has signed a new research agreement with global biopharmaceutical company AstraZeneca. The five-year initiative will see researchers from AstraZeneca and the Crick collaborate on early-stage research that could translate into new treatments and health innovations in the future.

23 May 2017

Scientists report promising approach to combat influenza and improve survival

The influenza virus turns infected lung cells into factories that churn out thousands of copies of the virus to spread the infection. St. Jude Children's Research Hospital scientists have reported a promising new approach that uses an investigational cancer drug to dial down viral production and dramatically increase survival of flu-infected mice.

23 May 2017

Study reveals health effects of exposure to particulate matter from residential heating and traffic

A study by researchers at the University of Tartu found that exposure to traffic-related particulate matter (PM) could be associated with cardiac diseases among people in the city of Tartu, Estonia, whereas PM from residential heating did not.

23 May 2017

Researchers synthesize lung surfactant by mimicking production of spider silk

Researchers at Karolinska Institutet in Sweden have managed to synthesise lung surfactant, a drug used in the care of preterm babies, by mimicking the production of spider silk.

23 May 2017

Study finds 22% antibiotic failure rate in pneumonia treatment

The new study presented at the 2017 American Thoracic Society International Conference has found that about 22.1%, approximately one in four adults, failed to respond to antibiotics for community-acquired pneumonia (CAP) treatment.

23 May 2017

Oxidative stress plays key role in development of recurrent wheezing following viral ARIs in infancy

Viral acute respiratory infections (ARIs) may lead to oxidative stress in some infants, and play a major role in the development of recurrent wheezing in early childhood, according to a new study presented at the 2017 American Thoracic Society International Conference.

23 May 2017

Respiratory News and Research

Study: Combining non-invasive ventilation and home oxygen therapy can reduce hospital readmissions for chronic COPD patients

FIRS releases new report that outlines global burden of respiratory disease

ERT’s Centralized LCI Services improve data quality to measure disease progression in respiratory clinical trials

Philips sponsors research to help COPD patients breathe easier

Bedfont Scientific named as one of top 25 companies on the Future List

EarlySense introduces new version of integrated patient monitoring and data analytics software platform

Zephyr Endobronchial Valves demonstrate clinical efficacy in heterogeneous and homogenous emphysema patients

BGU researchers redesign portion of FDA-approved drug into new molecule to treat ALS

BU professor receives Research Innovation and Translation Achievement Award from ATS

Innovus Pharma announces launch of AllerVarx for relieving nasal, ocular symptoms in allergic patients

Lung cancer diagnosis may put patients at greatest risk of suicide, study finds

Francis Crick Institute signs new research agreement with AstraZeneca

Scientists report promising approach to combat influenza and improve survival

Study reveals health effects of exposure to particulate matter from residential heating and traffic

Researchers synthesize lung surfactant by mimicking production of spider silk

Study finds 22% antibiotic failure rate in pneumonia treatment

Oxidative stress plays key role in development of recurrent wheezing following viral ARIs in infancy

Exposure to high prenatal stress and air pollution linked to increased risk for childhood asthma

Investigational biologic may reduce need for systemic corticosteroids in patients with severe asthma

Biomarker may predict death or poor pulmonary outcomes in extremely preterm infants

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News